The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.50
Ask: 18.00
Change: 0.00 (0.00%)
Spread: 0.50 (2.857%)
Open: 17.75
High: 17.75
Low: 17.75
Prev. Close: 17.75
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix obtains BRC accreditation

5 Jan 2022 07:00

RNS Number : 4249X
OptiBiotix Health PLC
05 January 2022
 

OptiBiotix Health plc

("OptiBiotix" or the "Company" or the "Group")

 

OptiBiotix obtains British Retail Consortium accreditation

One of the leading international food safety standards

 

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing unique science and human study-based compounds that modulate the microbiome to address metabolic syndrome and diabetes, systemic low-grade inflammation, obesity, cardiovascular disease, high cholesterol and to support healthy aging has achieved British Retail Consortium ('BRC') accreditation.

 

BRC was the first standard to meet the Global Food Safety Initiative ('GFSI') benchmark, which means it is accepted by many of the world's biggest retailers, such as Tesco and Walmart. The certification ensures customers have confidence in OptiBiotix's products and it allows the Company to do business with those retailers, manufacturers, ingredients companies and food service organisations who specify certification as part of their approval process (most large retailers and their suppliers). It incorporates food safety management systems and internationally accepted best practice to ensure the safety and quality of products and in doing so reduces the risk of recalls.

 

René Kamminga, CEO of OptiBiotix Limited, commented: "We are very pleased to announce our BRC accreditation which supports our commercial strategy of selling final product solutions to partners in the retail channel containing our science backed pro and prebiotic ingredients. I am particularly proud of our team which achieved this accreditation in a relatively short period of time."

 

For further information, please contact:

 

OptiBiotix Health plc

www.optibiotix.com

Stephen O'Hara, Chief Executive

Contact via Walbrook below

 

 

 

 

Cenkos Securities plc (Broker)

Tel: 020 7397 8900

Callum Davidson / Neil McDonald

 

Michael Johnson / Russell Kerr (Sales)

 

 

 

Walbrook PR Ltd

Mob: 07876 741 001

Anna Dunphy

 

 

 

This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSUFWLEESEFF
Date   Source Headline
3rd Jun 20155:50 pmRNSHolding(s) in Company
2nd Jun 20157:00 amRNSContract with multinational consumer goods company
29th May 20157:00 amRNSFinal Results
28th May 20157:00 amRNSNew patent filings
26th May 20157:01 amRNSExercise of Warrants and Issue of Equity
15th May 20153:22 pmRNSHolding(s) in Company
13th May 20157:00 amRNSNotice of Results
21st Apr 20152:24 pmRNSExercise of Warrants and Issue of Equity
17th Apr 20157:00 amRNSResearch Update
14th Apr 20157:00 amRNSUK Investor Show attendance
10th Apr 20154:35 pmRNSPrice Monitoring Extension
8th Apr 20155:26 pmRNSHolding(s) in Company
31st Mar 20155:32 pmRNSGrant of Options
25th Mar 201512:54 pmRNSHolding(s) in Company
20th Mar 201510:32 amRNSExercise of Warrants and Issue of Equity
10th Mar 20157:02 amRNSContract signed with NIZO Food Research
23rd Feb 20157:00 amRNSInvestor Teach In
18th Feb 20157:00 amRNSBoard Appointment
4th Feb 20154:03 pmRNSHolding(s) in Company
21st Jan 20157:00 amRNSJoint venture with Nizo Food Research
20th Jan 20153:23 pmRNSExercise of Warrants and Issue of Equity
15th Jan 20157:00 amRNSAdditions to Scientific Advisory Group
9th Jan 20152:24 pmRNSExercise of Warrants and Issue of Equity
15th Dec 20147:00 amRNSCompletion of ethics approval & study recruitment
10th Dec 20147:00 amRNSChange of Adviser
2nd Dec 20147:00 amRNSSuccessful completion of pre-clinical studies
28th Nov 20142:34 pmRNSHolding(s) in Company
28th Nov 20147:00 amRNSProduct showcased at Health Ingredients Europe
27th Nov 20144:57 pmRNSExercise of Warrants
25th Nov 20147:00 amRNSAppointment of Non-Executive Director
18th Nov 20147:00 amRNSAppointment of Head of Research
14th Nov 20142:46 pmRNSIssue of Equity
11th Nov 20147:00 amRNSContract Signed to Start Clinical Studies
28th Oct 20147:00 amRNSIncorporation of Weight Management Formulation
20th Oct 20147:00 amRNSScientific Advisory Group
1st Oct 20144:08 pmRNSExercise of Warrants
17th Sep 20147:00 amRNSContract signed with Nizo Food Research
5th Aug 20147:00 amRNSFirst day of dealings on AIM
4th Aug 20143:27 pmRNSChange of Name
4th Aug 201411:19 amRNSResult of General Meeting
18th Jul 20144:08 pmRNSExercise of Warrants and Issue of Equity
18th Jul 20147:30 amRNSSchedule 1 - Ducat Ventures plc
18th Jul 20147:30 amRNSRestoration - Ducat Ventures plc
18th Jul 20147:00 amRNSPublication of Admission Document & Restoration...
18th Jul 20147:00 amRNSHalf Yearly Results
9th May 201411:05 amRNSTemporary Suspension
9th May 201411:03 amRNSSuspension - Ducat Ventures Plc
24th Feb 20142:54 pmRNSResult of AGM
20th Feb 20149:10 amRNSResult of Open Offer and Issue of Equity
3rd Feb 20144:31 pmRNSFurther re Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.